Fc-fusion constructs binding to phosphatidylserine and their therapeutic use

Details for Australian Patent Application No. 2006206187 (hide)

Owner Board of Regents, The University of Texas System Peregrine Pharmaceuticals, Inc.

Inventors Luster, Troy A; King, Steven W.; Thorpe, Philip E

Agent Griffith Hack

Pub. Number AU-B-2006206187

PCT Pub. Number WO2006/079120

Priority 60/646,333 24.01.05 US

Filing date 24 January 2006

Wipo publication date 27 July 2006

Acceptance publication date 10 March 2011

International Classifications

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

A61K 38/37 (2006.01) Medicinal preparations containing peptides

A61K 38/48 (2006.01) Medicinal preparations containing peptides

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/079120 Priority application(s): WO2006/079120

10 March 2011 Application Accepted

  Published as AU-B-2006206187

7 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006206191-Metal vapour condensation and liquid metal withdrawal

2006206186-Modulation of Th2 lineage commitment by T-bet